To assess safety and efficacy of novel surgical therapies for vitreomacular interface disordersBackground:
Vitreomacular interface disorders are characterised by a combination of mechanical and biochemical interactions between the posterior hyaloid and the internal limiting membrane and the retinal surface in general. Pathologies that are amenable to surgical treatment include primarily epiretinal membranes and macular holes, but other less common maculopathies have been come to the forefront recently.Results:
This presentation will summarise the latest developments in the surgical therapy of vitreomacular interface disorders by evaluating the most recent data on advances in diagnostic tools for preoperative decision making, surgical technology and pharmacological combination therapies.Conclusion:
Novel surgical techniques are constantly increasing the therapeutic succes while reducing tissue irritation during surgery. New diagnostic approaches including high-resolution OCT can help the decision making and to predict visual acuity recovery after vitreomacular interface surgery.